List of insiders holdings for Kiniksa Pharmaceuticals International plc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 2025-06-05 17:06:51 | 29,680 2,839,604 | 2,869,284 | Form 4 |
| 2 | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Chen Bihua 10% Owner | 2019-02-14 16:14:48 | 831,000 0 | 831,000 | Form 13G |
| 3 | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare GP LLC Cormorant Global Healthcare Master Fund LP 10% Owner | 2019-02-14 16:14:48 | 831,000 0 | 831,000 | Form 13G |
| 4 | BOESS CARSTEN 10% Owner | 2018-05-29 19:19:09 | 559,016 0 | 559,016 | Form 4 |
| 5 | Patel Sanj K CHAIRMAN & CEO | 2025-05-28 17:25:05 | 240,223 109,795 | 350,018 | Form 4 |
| 6 | Paolini John F. CHIEF MEDICAL OFFICER | 2025-05-09 17:01:05 | 123,270 0 | 123,270 | Form 4 |
| 7 | Malley Thomas Director | 2025-06-05 17:02:16 | 32,143 71,967 | 104,110 | Form 4 |
| 8 | Mahoney Stephen F. President & COO | 2019-09-19 16:18:37 | 82,000 0 | 82,000 | Form 4 |
| 9 | Tessari Eben CHIEF OPERATING OFFICER | 2025-07-16 16:30:09 | 81,163 0 | 81,163 | Form 4 |
| 10 | Heberlig Chris EVP & CFO | 2019-09-19 16:16:52 | 50,000 0 | 50,000 | Form 4 |
| 11 | Quart Barry D Director | 2025-06-11 17:35:55 | 45,430 0 | 45,430 | Form 4 |
| 12 | Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-06-05 16:50:16 | 33,337 0 | 33,337 | Form 4 |
| 13 | Cole G Bradley Director | 2025-06-05 17:07:41 | 32,143 0 | 32,143 | Form 4 |
| 14 | McCain Tracey L Director | 2025-06-05 16:59:33 | 32,143 0 | 32,143 | Form 4 |
| 15 | Pano Arian Chief Clinical Dev. Officer | 2021-09-07 17:19:21 | 27,213 0 | 27,213 | Form 4 |
| 16 | Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-06-05 16:38:56 | 27,009 0 | 27,009 | Form 4 |
| 17 | Levy Richard S Director | 2025-07-03 16:39:40 | 19,575 0 | 19,575 | Form 4 |
| 18 | Popovits Kimberly J Director | 2025-08-01 16:36:07 | 12,546 0 | 12,546 | Form 4 |
| 19 | Beetham Thomas W. EVP & Chief Legal Officer | 2021-03-23 17:32:56 | 10,142 0 | 10,142 | Form 4 |
| 20 | Moat Ross CHIEF COMMERCIAL OFFICER | 2025-06-05 16:46:35 | 9,415 0 | 9,415 | Form 4 |
| 21 | Rizvi Qasim Chief Commercial Officer | 2021-01-05 17:07:03 | 5,176 0 | 5,176 | Form 4 |
| 22 | Boyd Meta Cantey Director | 2024-10-08 17:08:24 | 0 0 | 0 | Form 3 |
| 23 | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. *Possible member of 10% group 10% Owner | 2020-02-13 12:42:47 | 0 0 | 0 | Form 13G |
| 24 | Biggar Stephen R Director | 2018-05-23 20:23:42 | 0 0 | 0 | Form 3 |